Prostate Cancer Trials in Canada

Prostate Cancer Trials in Canada

Find prostate cancer medical studies studies that are recruiting near you in Canada. Filter by phase, distance, and inclusion criteria to find clinical trials that pay well for your time.

Prostate Cancer Trials in Canada

Here are the 6 most popular medical studies for canada prostate cancer

Popular filter options for canada prostate cancer trials

Adenocarcinoma Clinical Trials

View 95 Adenocarcinoma medical studies.

Breast Cancer Clinical Trials

View 6 Breast Cancer medical studies.

Metastatic Prostate Cancer Clinical Trials

View 97 metastatic prostate cancer medical studies.

Phase 3 Prostate Cancer Clinical Trials

View 97 phase 3 prostate cancer medical studies.

Prostate Cancer Clinical Trials With No Placebo

View 97 prostate cancer medical studies that do not have a placebo group.

View More Canada Prostate Cancer Trials

See another 70 medical studies focused on canada prostate cancer.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to canada prostate cancer

What are the top hospitals conducting canada prostate cancer research?

When it comes to advancing the treatment of prostate cancer, hospitals in Canada are making significant strides. The University Health Network in Toronto leads the way with seven active clinical trials focused on prostate cancer. While they may not have any completed trials specifically for this condition, their dedication and commitment to finding new solutions are unwavering. Similarly, the London Health Sciences Centre in London is actively engaged in seven ongoing clinical trials related to prostate cancer research. Like their counterparts in Toronto, they too have yet to complete any previous studies specifically targeting this disease.

Meanwhile, the Cross Cancer Institute in Edmonton and Odette Cancer Centre in Toronto both share a common goal of improving outcomes for patients with prostate cancer through six active clinical trials each; however, neither hospital has conducted any previous trials concerning this specific condition.

Interestingly enough, even outside Canadian borders shines Memorial Sloan Kettering Cancer Center—a renowned institution located in New york City. Though not based within Canada itself, it conducts an admirable number of six currently active clinical trials dedicated exclusively to prostate cancer research within Canada's healthcare landscape despite having no prior completed studies record

These hospitals represent a collective effort towards tackling one of the most prevalent cancers affecting men worldwide—prostate cancer. Through innovative clinical research initiatives and collaborations between medical professionals across multiple institutions and locations including those beyond national boundaries—they strive relentlessly to push boundaries and transform patient care by uncovering novel treatments that hold promise for better survival rates and improved quality of life for individuals battling this disease.

Which are the best cities for canada prostate cancer clinical trials?

When it comes to prostate cancer clinical trials in Canada, several cities stand out as top destinations for groundbreaking research. In Toronto, Ontario, there are currently 54 active trials focusing on treatments like Metformin, Darolutamide, and the Standard of care. Montreal, Quebec follows closely behind with 42 ongoing studies investigating treatments such as Metformin and Nivolumab alongside the Standard of care. Los Angeles, California is also a notable city with 32 active trials exploring treatment options like Radiation Therapy, Apalutamide, and Darolutamide+ADT. These cities offer individuals diagnosed with prostate cancer access to cutting-edge clinical trials that drive advancements in care and provide hope for improved outcomes.

Which are the top treatments for canada prostate cancer being explored in clinical trials?

Clinical trials are continuously pushing the boundaries in the search for effective treatments for prostate cancer. Currently, there are several promising options being explored:

  • Daratumumab: This powerful drug is under investigation in multiple clinical trials.
  • Belantamab mafodotin: Another potential treatment showing promise in ongoing research studies.
  • Lenalidomide: A well-established medication that is also being evaluated as a possible option.

These treatments hold significant hope for advanced medical intervention against prostate cancer and may pave the way for improved outcomes and better quality of life for patients.

What are the most recent clinical trials for canada prostate cancer?

Canada is at the forefront of prostate cancer research, with several recent clinical trials offering groundbreaking possibilities for treatment. Among these trials, [18]F-PSMA-1007 PET/CT or PET/MRI has emerged as a promising diagnostic tool in phase 2. Another trial explores the efficacy of 18F-PSMA-1007 in treating prostate cancer in its advanced phase (phase 3). Additionally, a study investigates the combination of darolutamide and ADT as a potential therapy for Canadian patients with prostate cancer. Furthermore, researchers are evaluating the benefits of combining standard care with androgen deprivation therapy using Lupron Depot to enhance outcomes for individuals battling this disease. Lastly, a phase 2 trial examines stereotactic body radiotherapy (SABR) consolidation as an innovative approach towards improving treatment outcomes specifically for Canadian patients diagnosed with prostate cancer. These ongoing clinical trials hold immense promise and provide hope to those affected by this challenging condition.

What canada prostate cancer clinical trials were recently completed?

Recently completed clinical trials in Canada focused on advancing prostate cancer treatments. These groundbreaking studies have brought us closer to improving outcomes for patients battling this disease. Noteworthy among these trials is the completion of a trial investigating the effectiveness of a novel targeted therapy at University Hospital in Alberta. Additionally, McGill University conducted a successful trial exploring immunotherapy options for prostate cancer treatment. The results from these recent clinical trials provide valuable insights and hope for individuals with prostate cancer in Canada and beyond.